Current Ratio
Updated 56h ago
Sector Performance
8th percentileMDLZ
0.54x
Sector Median
1.20x
Sector Avg
2.57x
Deep Analysis
MDLZ’s current ratio of 0.54x means the company has only $0.54 in current assets—cash, receivables, and inventory—for every $1 of short-term liabilities, signaling potential difficulty covering upcoming obligations.
This is sharply below the sector median of 1.20x and places MDLZ in the 8th percentile among sector peers, indicating one of the lowest liquidity positions in its group. The trend data is not available: the year-over-year change, quarter-over-quarter change, and last 8 quarters are all listed as N/A, so no directional conclusion can be drawn from history. The combination of a very low current ratio with no trend information suggests a current liquidity risk that is not confirmed as improving or worsening, creating a watchful scenario for investors. This metric directly contradicts the overall NEUTRAL verdict, as a ratio well below 1.0x typically raises a red flag about financial flexibility, yet the absence of trend data leaves the assessment reliant on this single weak data point.
Frequently Asked Questions
What does the Current Ratio tell investors about MDLZ?
Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.
How is the Current Ratio calculated?
Current Ratio is calculated as: Current Assets / Current Liabilities.
Who are MDLZ's closest peers by Current Ratio?
The closest peers by Current Ratio include: SPG (0.41x), CHTR (0.40x), USB (0.40x), GEN (0.40x), DRI (0.39x).
The Formula
Current Assets / Current Liabilities
Why It Matters
Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.
Master MDLZ's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full MDLZ research report →MDLZ
0.54x
Sector Median
1.20x
Sector Avg
2.57x
How MDLZ's Current Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.